Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Yiliang Yang"'
Autor:
Wuyang Zhu, Lihua Wang, Yiliang Yang, Juan Jia, Shihong Fu, Yun Feng, Ying He, Jin-Ping Li, Guodong Liang
Publikováno v:
PLoS ONE, Vol 5, Iss 3, p e9656 (2010)
Cell culture-adapted strains of Sindbis virus (SINV) initially attach to cells by the ability to interact with heparan sulfate (HS) through selective mutation for positively charged amino acid (aa) scattered in E2 glycoprotein (W. B. Klimstra, K. D.
Externí odkaz:
https://doaj.org/article/7e9070fae8e049bf84dd501c1969c63c
Autor:
Datong Gao, Meng Lin, Yiwei Peng, Jiajia Li, Yiliang Yang, Yulu Teng, Siyu Chen, Wen Sun, Zinan W1, Quan Yu, Zhenzhen Yang, Yanxia Zhou, Xinru Li, Xianrong Qi
Publikováno v:
Journal of Chinese Pharmaceutical Sciences; Mar2024, Vol. 33 Issue 3, p189-200, 12p
Autor:
Mou Wang, Sheng Yin, Zhirong Zhang, Qin He, Yiliang Yang, Shanshan Xu, Man Li, Yashi Wang, Lin Mei, Xuan He
Publikováno v:
Journal of Controlled Release. 321:71-83
Oxidative-stress defense system stands for the vulnerability of tumor cells because of the stronger oxidative stress existing in tumor sites. TRPA-1 has been found to be overexpressed in various tumors, related to the tumor proliferation and metastas
Autor:
Xian Tang, Zhirong Zhang, Man Li, Hanbing Xie, Yiliang Yang, Jianping Li, Mengmeng Li, Yingke Liu, Qianwen Yu, Lifeng Tian, Qin He, Kebai Ren
Publikováno v:
Journal of Controlled Release. 321:23-35
Immunotherapy has exhibited great potential in cancer treatment. However, for immunosuppressive tumors such as pancreatic cancer, immunotherapy is far from satisfactory. PI3K-γ and colony stimulating factor-1/colony stimulating factor-1 receptor (CS
Autor:
Kebai Ren, Jiao He, Yue Qiu, Zhuping Xu, Xuhui Wang, Jiaxin Li, Shuya Zang, Yiliang Yang, Yang Long, Zhirong Zhang, Man Li, Qin He
Publikováno v:
Acta biomaterialia. 145
Recurrence and metastasis after resection are still the main challenges in clinical treatment of breast cancer. Residual tumor and cancer stem-like cells are the primary culprits of recurrence and metastasis. Recent research studies indicate that aut
A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma
Autor:
Yuling Liu, Yufan Xiang, Man Li, Mingrong Zuo, Qing Mao, Yiliang Yang, Xianding Wang, Shangfu Zhang, Ruofei Liang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer
BMC Cancer
Background Post-operative pneumonia (Pop) following meningioma surgery is the dominant systemic complication which could cause serious threats to patients. It is unclear whether hematological biochemical markers are independently associated with the
Autor:
Zhirong Zhang, Wei Zhao, Xian Tang, Man Li, Xingli Cun, Qin He, Shanshan Xu, Yue Qiu, Yiyao Liu, Yiliang Yang, Yangyang Xiang, Dandan Wan, Qianwen Yu
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 317
Myeloid-derived suppressor cells(MDSCs)are one of the most important immunosuppressive cells in tumor microenvironment, which also promote the development and progression of tumor cells. Nevertheless, due to the different distribution features of MDS
Publikováno v:
International Journal of Pharmaceutics. 577:119085
Tumor growth and metastasis are multistep processes regulated by multiple signaling pathways. The successful treatment of cancer largely depends on the ability to inhibit metastatic process. Multiphase inhibition of metastasis is a promising approach
Autor:
Xingli Cun, Man Li, Zhengze Lu, Yang Long, Xuhui Wang, Jianping Li, Zhirong Zhang, Yiliang Yang, Ling Mei, Qin He
Publikováno v:
Nanoscale. 10(21)
Cancer-related inflammation can promote tumorigenesis, tumor growth and tumor metastasis in many types of cancers. Therefore, inhibiting cancer-related inflammation significantly improves cancer therapy. It has been reported that metformin (MET) inhi
Autor:
Frances Chung, Pu Liao, Weimin Kang, Babak Mokhlesi, Maged Andrawes, Colin M. Shapiro, Yiliang Yang
Publikováno v:
Anesthesia & Analgesia. 120:1214-1224
Recently published data show that postoperative apnea-hypopnea index (AHI) is significantly increased in some patients without preoperative sleep apnea. These patients may be at risk of developing perioperative adverse events related to sleep-disorde